“Evaluating the Clinical Efficacy and Safety of Subcutaneous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review”. (2024) 2024. The Medical Journal of General Medicine 1 (1): 1-16. https://medicaljournalinternational.org/tmjgm/article/view/1.